IMRIS

Analysts

The investment firms and equity analysts listed below provide research reports on IMRIS. Opinions, estimates, forecasts or other analyses, including prior or future IMRIS performance from any source is the opinion of the writer and is theirs alone and does not represent the opinions, estimates or forecasts of IMRIS or its management. The Company does not, by any reference below, imply any endorsement of, or concurrence with, information, conclusions drawn or recommendations offered by property of the author.

IMRIS does not distribute research reports, which are the property of the author.

Alan Ridgeway, Ph.D.
Analyst - Biotech and Health Care
Paradigm Capital
95 Wellington Street West, Suite 2101
Toronto, ON, M5J 2N7

T 416.361.9080
E aridgeway@paradigmcap.com

Douglas W. Loe, Ph.D, MBA
Analyst - Healthcare & Biotechnology
Versant Partners Inc.
20 Queen Street West, Suite 3110
Toronto, ON, M5H 3R3

T 416.849.5005
E DLoe@versantpartners.com

Douglas Miehm
Biotech & Pharmaceutical Research
RBC Dominion Securities Inc
Royal Bank Plaza
South Tower, 3rd Flr
Toronto, ON, M5J 2W7

T 416.842.7823
E douglas.miehm@rbccm.com

Cosme Ordonez, MD, PhD
GMP Securities L.P.
1250 Rene Levesque Blvd.
15th Floor
Montréal, QC, H3B 4W8

T 514.288.9279
E cosmeo@gmpsecurities.com

Neil Maruoka
Life Sciences - Biomedical Devices and Services
Canaccord Adams
PO Box 516
161 Bay Street, Suite 3000
Toronto, Ontario
M5J 2S1

T 416.869.3073
E neil.maruoka@canaccordadams.com